findmyKOL

Adhir Shroff, MD

Basic profile

University of Illinois Chicago

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Adhir Shroff is a Cardiology physician affiliated with University of Illinois Chicago. OpenAlex indexes 197 publications with 2,680 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
197publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,680citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    76.9%
    Beta blocker22%
    Metoprolol Succinate57%Carvedilol26%Metoprolol Tartrate17%
    Part D<11 patients
    PCSK9 Inhibitor13.9%
    Praluent Pen100%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    14.2%
    Factor Xa inhibitor7.8%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor6.4%
    Brilinta50%Clopidogrel50%
    Part D<11 patients
  • Metabolism & gastrointestinal

    8.8%
    SGLT2 inhibitor8.8%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”